Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune-checkpoint Inhibitors and Surrogate Endpoints in Cancer Trials

NCT03963518 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT03963518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03963518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune-checkpoint Inhibitors and Surrogate Endpoints in Cancer Trials
Lead sponsor
Institut Bergonié
Phase
Observational
Overall status
Completed
Start date
January 31, 2017
Completion date
December 31, 2020
Enrollment
631 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer treated with immune-checkpoint inhibitors